Karyopharm Therapeutics | KPTI - Dividendenrendite

Aktienkurs
8.00
Täglich Wechseln
-0.16 -1.96%
Monatlich
-8.57%
Jährlich
86.48%
Q2 Prognose
7.78




Dy Veränderung Datum
AbbVie 2.91 0.58 2025-12
Abbott 1.92 0.15 2025-12
Amgen 2.95 0.38 2025-12
AstraZeneca USD 1.74 0.4 2025-12
BioCryst Pharmaceuticals 0 0 2025-03
Bristol-Myers Squibb 0.22 0.04 2025-12
Eli Lilly 0.58 0.16 2025-12
Enanta Pharmaceuticals 0 0 2025-03
GlaxoSmithKline 4.57 1.52 2025-12
J&J 2.5 0.32 2025-12
Karyopharm Therapeutics 0 0 2025-03
Merck 3.12 0.74 2025-12
Nektar Therapeutics 0 0 2025-03
Novartis USD 3.05 0.26 2025-12
Novartis 2.9 0.22 2025-12
Pfizer 6.91 0.33 2025-12
Regeneron Pharmaceuticals 0.46 0.01 2025-12
Roche Holding 2.96 0.8 2025-12
Sangamo BioSciences 0 0 2025-03
Takeda 4.08 0.46 2025-12